Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia
Conditions:   Hypertension;   Dyslipidemias Intervention:   Drug: Olmesartan Medoxomil/ Amlodipine Besylate/ Rosuvastatin Ca Sponsor:   Daewoong Pharmaceutical Co. LTD. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2022 Category: Research Source Type: clinical trials